{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T14:49:05Z","timestamp":1783435745428,"version":"3.54.6"},"reference-count":37,"publisher":"American Association for Cancer Research (AACR)","issue":"19","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Bone marrow\u2013derived dendritic cells engineered using recombinant adenovirus to secrete high levels of IL-12p70 dramatically inhibited the growth of established CMS4 sarcomas in BALB\/c mice after intratumoral administration. An analysis of splenic CD8+ T cells in regressor mice revealed a strong, complex reactivity pattern against high-performance liquid chromatography (HPLC)\u2013resolved peptides isolated by acid elution from single-cell suspensions of surgically resected CMS4 lesions. Mass spectrometry analyses defined two major overlapping peptide species that derive from the murine hemoglobin-\u03b2 (HBB) protein within the most stimulatory HPLC fractions. Although cultured CMS4 tumor cells failed to express HBB mRNA based on reverse transcription-PCR analyses, prophylactic vaccination of BALB\/c mice with vaccines containing HBB peptides promoted specific CD8+ T-cell responses that protected mice against a subsequent challenge with CMS4 or unrelated syngeneic (HBBneg) tumors of divergent histology (sarcoma, carcinomas of the breast or colon). In situ imaging suggested that vaccines limit or destabilize tumor-associated vascular structures, potentially by promoting immunity against HBB+ vascular pericytes. Importantly, there were no untoward effects of vaccination with the HBB peptide on peripheral RBC numbers, RBC hemoglobin content, or vascular structures in the brain or eye. [Cancer Res 2008;68(19):8076\u201384]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-0387","type":"journal-article","created":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:53:23Z","timestamp":1222822403000},"page":"8076-8084","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["CD8+ T-Cell Responses against Hemoglobin-\u03b2 Prevent Solid Tumor Growth"],"prefix":"10.1158","volume":"68","author":[{"given":"Hideo","family":"Komita","sequence":"first","affiliation":[{"name":"1Dermatology, Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhao","sequence":"additional","affiliation":[{"name":"1Dermatology, Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Taylor","sequence":"additional","affiliation":[{"name":"1Dermatology, Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis J.","family":"Sparvero","sequence":"additional","affiliation":[{"name":"2Surgery,"},{"name":"6University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Amoscato","sequence":"additional","affiliation":[{"name":"2Surgery,"},{"name":"3Pathology,"},{"name":"6University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Alber","sequence":"additional","affiliation":[{"name":"4Cell Biology and Physiology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon C.","family":"Watkins","sequence":"additional","affiliation":[{"name":"4Cell Biology and Physiology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela D.","family":"Pardee","sequence":"additional","affiliation":[{"name":"5Immunology, University of Pittsburgh School of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy K.","family":"Wesa","sequence":"additional","affiliation":[{"name":"1Dermatology, Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter J.","family":"Storkus","sequence":"additional","affiliation":[{"name":"1Dermatology, Departments of"},{"name":"5Immunology, University of Pittsburgh School of Medicine and"},{"name":"6University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2008,9,30]]},"reference":[{"key":"2022061700261010600_B1","unstructured":"Tatsumi T, Huang J, Gooding WE, et al. Intratumoral delivery of dendritic cells engineered to secrete both interleukin (IL)-12 and IL-18 effectively treats local and distant disease in association with broadly reactive Tc1-type immunity. Cancer Res\u20082003; 63: 6378\u201386."},{"key":"2022061700261010600_B2","doi-asserted-by":"crossref","unstructured":"Bergers G, Song S. The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol\u20082005; 7: 452\u201364.","DOI":"10.1215\/S1152851705000232"},{"key":"2022061700261010600_B3","doi-asserted-by":"crossref","unstructured":"Ganss R. Tumor stroma fosters neovascularization by recruitment of progenitor cells into the tumor bed. J Cell Mol Med\u20082006; 10: 857\u201365.","DOI":"10.1111\/j.1582-4934.2006.tb00530.x"},{"key":"2022061700261010600_B4","doi-asserted-by":"crossref","unstructured":"von Tell D, Armulik A, Betsholtz C. Pericytes and vascular stability. Exp Cell Res\u20082006; 312: 623\u20139.","DOI":"10.1016\/j.yexcr.2005.10.019"},{"key":"2022061700261010600_B5","doi-asserted-by":"crossref","unstructured":"Hammes HP, Lin J, Renner O, et al. Pericytes and the pathogenesis of diabetic retinopathy. Diabetes\u20082002; 51: 3107\u201312.","DOI":"10.2337\/diabetes.51.10.3107"},{"key":"2022061700261010600_B6","doi-asserted-by":"crossref","unstructured":"Braun A, Xu H, Hu F, et al. Paucity of pericytes in germinal matrix vasculature of premature infants. J Neurosci\u20082007; 27: 12012\u201324.","DOI":"10.1523\/JNEUROSCI.3281-07.2007"},{"key":"2022061700261010600_B7","doi-asserted-by":"crossref","unstructured":"Baluk P, Hashizume H, McDonald DM. Cellular abnormalities of blood vessels as targets in cancer. Curr Opin Genet Dev\u20082005; 15: 102\u201311.","DOI":"10.1016\/j.gde.2004.12.005"},{"key":"2022061700261010600_B8","doi-asserted-by":"crossref","unstructured":"Lindahl P, Johansson BR, Leve\u0301en P, Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-\u03b2-deficient mice. Science\u20081997; 277: 242\u20135.","DOI":"10.1126\/science.277.5323.242"},{"key":"2022061700261010600_B9","doi-asserted-by":"crossref","unstructured":"Kaplan CD, Kru\u0308ger JA, Zhou H, Luo Y, Xiang R, Reisfeld RA. A novel DNA vaccine encoding PDGFR\u03b2 suppresses growth and dissemination of murine colon, lung and breast carcinoma. Vaccine\u20082006; 24: 6994\u20137002.","DOI":"10.1016\/j.vaccine.2006.04.071"},{"key":"2022061700261010600_B10","doi-asserted-by":"crossref","unstructured":"Storkus WJ, Zeh HJ III, Maeurer MJ, Salter RD, Lotze MT. Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes. J Immunol\u20081993; 151: 3719\u201327.","DOI":"10.4049\/jimmunol.151.7.3719"},{"key":"2022061700261010600_B11","doi-asserted-by":"crossref","unstructured":"Herr W, Ranieri E, Gambotto A, et al. Identification of naturally processed and HLA-presented Epstein-Barr virus peptides recognized by CD4+ or CD8+ T lymphocytes from human blood. Proc Natl Acad Sci U S A\u20081999; 96: 12033\u20138.","DOI":"10.1073\/pnas.96.21.12033"},{"key":"2022061700261010600_B12","doi-asserted-by":"crossref","unstructured":"Ochoa-Garay J, McKinney DM, Kochounian HH, McMillan M. The ability of peptides to induce cytotoxic T cells in vitro does not strongly correlate with their affinity for the H-2Ld molecule: implications for vaccine design and immunotherapy. Mol Immunol\u20081997; 34: 273\u201381.","DOI":"10.1016\/S0161-5890(97)00019-9"},{"key":"2022061700261010600_B13","doi-asserted-by":"crossref","unstructured":"Berhanu A, Huang J, Alber SM, Watkins SC, Storkus WJ. Combinational rFlt3-ligand and rGM-CSF treatment promotes enhanced tumor infiltration by dendritic cells and anti-tumor CD8+ T cell cross-priming, but is ineffective as a therapy. Cancer Res\u20082006; 66: 4895\u2013903.","DOI":"10.1158\/0008-5472.CAN-05-2384"},{"key":"2022061700261010600_B14","unstructured":"Kahn SE, Watkins BF, Bernes EW, Jr. An evaluation of a spectrophotometric scanning technique for the rapid determination of plasma hemoglobin. Ann Clin Lab Sci\u20081981; 11: 126\u201331."},{"key":"2022061700261010600_B15","doi-asserted-by":"crossref","unstructured":"Borda JT, Alvarez X, Mohan M, et al. CD163, a marker of perivascular macrophages, is up-regulated by microglia in simian immunodeficiency virus encephalitis after haptoglobin-hemoglobin complex stimulation and is suggestive of breakdown of the blood-brain barrier. Am J Pathol\u20082008; 172: 725\u201337.","DOI":"10.2353\/ajpath.2008.070848"},{"key":"2022061700261010600_B16","doi-asserted-by":"crossref","unstructured":"Hirano N, Butler MO, Xia Z, et al. Identification of an immunogenic CD8+ T-cell epitope derived from \u03b3-globin, a putative tumor-associated antigen for juvenile myelomonocytic leukemia. Blood\u20082006; 108: 2662\u20138.","DOI":"10.1182\/blood-2006-04-017566"},{"key":"2022061700261010600_B17","doi-asserted-by":"crossref","unstructured":"Stamatoyannopoulos G. Control of globin gene expression during development and erythroid differentiation. Exp Hematol\u20082005; 33: 259\u201371.","DOI":"10.1016\/j.exphem.2004.11.007"},{"key":"2022061700261010600_B18","doi-asserted-by":"crossref","unstructured":"Liu L, Zeng M, Stamler JS. Hemoglobin induction in mouse macrophages. Proc Natl Acad Sci U S A\u20081999; 96: 6643\u20137.","DOI":"10.1073\/pnas.96.12.6643"},{"key":"2022061700261010600_B19","doi-asserted-by":"crossref","unstructured":"Bhaskaran M, Chen H, Chen Z, Liu L. Hemoglobin is expressed in alveolar epithelial type II cells. Biochem Biophys Res Commun\u20082005; 333: 1348\u201352.","DOI":"10.1016\/j.bbrc.2005.06.042"},{"key":"2022061700261010600_B20","doi-asserted-by":"crossref","unstructured":"Gorr TA, Cahn JD, Yamagata H, Bunn HF. Hypoxia-induced synthesis of hemoglobin in the crustacean Daphnia magna is hypoxia-inducible factor-dependent. J Biol Chem\u20082004; 279: 36038\u201347.","DOI":"10.1074\/jbc.M403981200"},{"key":"2022061700261010600_B21","doi-asserted-by":"crossref","unstructured":"Bichet S, Wenger RH, Camenisch G, et al. Oxygen tension modulates \u03b2-globin switching in embryoid bodies. FASEB J\u20081999; 13: 285\u201395.","DOI":"10.1096\/fasebj.13.2.285"},{"key":"2022061700261010600_B22","doi-asserted-by":"crossref","unstructured":"Dewever J, Fre\u0301rart F, Bouzin C, et al. Caveolin-1 is critical for the maturation of tumor blood vessels through the regulation of both endothelial tube formation and mural cell recruitment. Am J Pathol\u20082007; 171: 1619\u201328.","DOI":"10.2353\/ajpath.2007.060968"},{"key":"2022061700261010600_B23","doi-asserted-by":"crossref","unstructured":"Lin M, Yu J, Murata T, Sessa WC. Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis and growth. Cancer Res\u20082007; 67: 2849\u201356.","DOI":"10.1158\/0008-5472.CAN-06-4082"},{"key":"2022061700261010600_B24","doi-asserted-by":"crossref","unstructured":"Faivre-Fiorina B, Caron A, Fassot C, et al. Presence of hemoglobin inside aortic endothelial cells after cell-free hemoglobin administration in guinea pigs. Am J Physiol\u20081999; 276: H766\u201370.","DOI":"10.1152\/ajpheart.1999.276.2.H766"},{"key":"2022061700261010600_B25","doi-asserted-by":"crossref","unstructured":"Moestrup SK, M\u00f8ller HJ. CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Ann Med\u20082004; 36: 347\u201354.","DOI":"10.1080\/07853890410033171"},{"key":"2022061700261010600_B26","doi-asserted-by":"crossref","unstructured":"Fabriek BO, Dijkstra CD, van den Berg TK. The macrophage scavenger receptor CD163. Immunobiology\u20082005; 210: 153\u201360.","DOI":"10.1016\/j.imbio.2005.05.010"},{"key":"2022061700261010600_B27","doi-asserted-by":"crossref","unstructured":"Kruckeberg WC, Doorenbos DI, Brown PO. Genetic differences in hemoglobin influence on erythrocyte oxidative stress hemolysis. Blood\u20081987; 70: 909\u201314.","DOI":"10.1182\/blood.V70.4.909.909"},{"key":"2022061700261010600_B28","doi-asserted-by":"crossref","unstructured":"Poole RK, Hughes MN. New functions for the ancient globin family: bacterial responses to nitric oxide and nitrosative stress. Mol Microbiol\u20082000; 36: 775\u201383.","DOI":"10.1046\/j.1365-2958.2000.01889.x"},{"key":"2022061700261010600_B29","doi-asserted-by":"crossref","unstructured":"Gladwin MT, Ognibene FP, Pannell LK, et al. Relative role of heme nitrosylation and \u03b2-cysteine 93 nitrosation in the transport and metabolism of nitric oxide by hemoglobin in the human circulation. Proc Natl Acad Sci U S A\u20082000; 97: 9943\u20138.","DOI":"10.1073\/pnas.180155397"},{"key":"2022061700261010600_B30","doi-asserted-by":"crossref","unstructured":"Roesch-Ely M, Nees M, Karsai S, et al. Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer. Oncogene\u20082007; 26: 54\u201364.","DOI":"10.1038\/sj.onc.1209770"},{"key":"2022061700261010600_B31","doi-asserted-by":"crossref","unstructured":"Ramage JM, Metheringham R, Conn A, et al. Identification of an HLA-A*0201 cytotoxic T lymphocyte epitope specific to the endothelial antigen Tie-2. Int J Cancer\u20082004; 110: 245\u201350.","DOI":"10.1002\/ijc.20120"},{"key":"2022061700261010600_B32","doi-asserted-by":"crossref","unstructured":"Dong Y, Qian J, Ibrahim R, Berzofsky JA, Khleif SN. Identification of H-2Db-specific CD8+ T-cell epitopes from mouse VEGFR2 that can inhibit angiogenesis and tumor growth. J Immunother\u20082006; 29: 32\u201340.","DOI":"10.1097\/01.cji.0000175494.13476.56"},{"key":"2022061700261010600_B33","doi-asserted-by":"crossref","unstructured":"Wada S, Tsunoda T, Baba T, et al. Rationale for antiangiogenic cancer therapy with vaccination using epitope peptides derived from human vascular endothelial growth factor receptor 2. Cancer Res\u20082005; 65: 4939\u201346.","DOI":"10.1158\/0008-5472.CAN-04-3759"},{"key":"2022061700261010600_B34","doi-asserted-by":"crossref","unstructured":"Ishizaki H, Tsunoda T, Wada S, Yamauchi M, Shibuya M, Tahara H. Inhibition of tumor growth with antiangiogenic cancer vaccine using epitope peptides derived from human vascular endothelial growth factor receptor 1. Clin Cancer Res\u20082006; 12: 5841\u20139.","DOI":"10.1158\/1078-0432.CCR-06-0750"},{"key":"2022061700261010600_B35","doi-asserted-by":"crossref","unstructured":"Lu C, Kamat AA, Lin YG, et al. Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma. Clin Cancer Res\u20082007; 13: 4208\u201317.","DOI":"10.1158\/1078-0432.CCR-07-0197"},{"key":"2022061700261010600_B36","doi-asserted-by":"crossref","unstructured":"Evel-Kabler K, Song XT, Aldrich M, Huang XF, Chen SY. SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling. J Clin Invest\u20082006; 116: 90\u2013100.","DOI":"10.1172\/JCI26169"},{"key":"2022061700261010600_B37","doi-asserted-by":"crossref","unstructured":"Belladonna ML, Grohmann U, Bianchi R, et al. The role of IL-12 in the induction of an immune response to a tumor\/self peptide: prevention and reversion of anergy. J Chemother\u20081998; 10: 157\u20139.","DOI":"10.1179\/joc.1998.10.2.157"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/19\/8076\/2596074\/8076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/19\/8076\/2596074\/8076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T01:52:22Z","timestamp":1684547542000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/68\/19\/8076\/541205\/CD8-T-Cell-Responses-against-Hemoglobin-Prevent"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,30]]},"references-count":37,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2008,9,30]]},"published-print":{"date-parts":[[2008,10,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-0387","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22374162.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6497355.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374171.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374159.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6497355","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374168.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374168","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374159","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374165","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374165.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374171","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374162","asserted-by":"object"}],"has-review":[{"id-type":"doi","id":"10.3410\/f.1157475.617639","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,30]]}}}